The functional interactome of GSTP: A regulatory biomolecular network at the interface with the Nrf2 adaption response to oxidative stress

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1019, Issue , 2016, Pages 29-44

  Bartolini, Desirée ^a   Galli, Francesco ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Glutathione S transferase P; Interaction proteomics; Interactome; Nrf2; Regulatory network; Stress adaption response

Indexed keywords

BIOCHEMISTRY; DETOXIFICATION; MOLECULAR BIOLOGY; PEPTIDES; PROTEINS; TRANSCRIPTION;

GLUTATHIONE S-TRANSFERASES; INTERACTOME; NRF2; PROTEOMICS; REGULATORY NETWORK;

CELL SIGNALING;

GLUTATHIONE TRANSFERASE P1; PEROXIREDOXIN 6; STAT3 PROTEIN; TRANSCRIPTION FACTOR NRF2; GLUTATHIONE TRANSFERASE; PROTEIN BINDING;

HUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; METABOLISM; PROCEDURES; PROTEIN ANALYSIS;

ANIMALS; GLUTATHIONE TRANSFERASE; HUMANS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SIGNAL TRANSDUCTION;

EID: 84976209191     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2016.02.002     Document Type: Review

References (107)

1. Mannervik B., Board P.G., Hayes J.D., Listowsky I., Pearson W.R. Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol. 2005, 401:1-8.
2. Higgins L.G., Hayes J.D. Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflammatory agents. Drug Metab. Rev. 2011, 43:92-137.
3. Kitteringham N.R., Powell H., Jenkins R.E., Hamlett J., Lovatt C., Elsby R., Henderson C.J., Wolf C.R., Pennington S.R., Park B.K. Protein expression profiling of glutathione S-transferase pi null mice as a strategy to identify potential markers of resistance to paracetamol-induced toxicity in the liver. Proteomics 2003, 3:191-207.
4. Hayes J.D., McMahon M., Chowdhry S., Dinkova-Kostova A.T. Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid. Redox Signal. 2010, 13:1713-1748.
5. Hayes J.D., McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem. Sci. 2009, 34:176-188.
6. Conklin D.J., Haberzettl P., Lesgards J.F., Prough R.A., Srivastava S., Bhatnagar A. Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity. J. Pharmacol. Exp. Ther. 2009, 331:456-469.
7. Tew K.D., Townsend D.M. Regulatory functions of glutathione S-transferase P 1-1 unrelated to detoxification. Drug Metab. Rev. 2011, 43:179-193.
8. Bartolini D., Commodi J., Piroddi M., Incipini L., Sancineto L., Santi C., Galli F. Glutathione S-transferase pi expression regulates the Nrf2-dependent response to hormetic diselenides. Free Radic. Biol. Med. 2015, 88:466-480.
9. Kobayashi Y. A study on diagnosis of oral squamous cell carcinoma (oral SCC) by glutathione S-transferase-pi (GST-pi). Kokubyo Gakkai Zasshi 1999, 66:46-56.
10. Hartwell L.H., Hopfield J.J., Leibler S., Murray A.W. From molecular to modular cell biology. Nature 1999, 402:C47-52.
11. Kitano H. Computational systems biology. Nature 2002, 420:206-210.
12. Vasieva O. The many faces of glutathione transferase pi. Curr. Mol. Med. 2011, 11:129-139.
13. Fabrini R., Bocedi A., Del Grosso E., Morici L., Federici G., Palleschi A., Ricci G. Erythrocyte glutathione transferase: a novel biomarker to check environmental pollution hazardous for humans. Biochem. Biophys. Res. Commun. 2012, 426:71-75.
14. Galli F., Piroddi M., Bartolini D., Ciffolilli S., Buoncristiani E., Ricci G., Buoncristiani U. Blood thiol status and erythrocyte glutathione-S-transferase in chronic kidney disease patients on treatment with frequent (daily) hemodialysis. Free Radic. Res. 2014, 48:273-281.
15. Mimic-Oka J., Simic T., Djukanovic L., Stefanovski J., Ramic Z. Glutathione and its associated enzymes in peripheral blood cells in different stages of chronic renal insufficiency. Amino Acids 1992, 2:215-224.
16. Galli F., Rovidati S., Benedetti S., Buoncristiani U., Covarelli C., Floridi A., Canestrari F. Overexpression of erythrocyte glutathione S-transferase in uremia and dialysis. Clin. Chem. 1999, 45:1781-1788.
17. Carmagnol F., Sinet P.M., Rapin J., Jerome H. Glutathione-S-transferase of human red blood cells; assay, values in normal subjects and in two pathological circumstances: hyperbilirubinemia and impaired renal function. Clin. Chim. Acta 1981, 117:209-217.
18. Litwack G., Ketterer B., Arias I.M. Ligandin: a hepatic protein which binds steroids, bilirubin, carcinogens and a number of exogenous organic anions. Nature 1971, 234:466-467.
19. Prade L., Huber R., Manoharan T.H., Fahl W.E., Reuter W. Structures of class pi glutathione S-transferase from human placenta in complex with substrate, transition-state analogue and inhibitor. Structure 1997, 5:1287-1295.
20. Mitsuishi Y., Motohashi H., Yamamoto M. The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Front. Oncol. 2012, 2:200.
21. Barabasi A.L., Gulbahce N., Loscalzo J. Network medicine: a network-based approach to human disease. Nat. Rev. Gene.t 2011, 12:56-68.
22. Vidal M., Cusick M.E., Barabasi A.L. Interactome networks and human disease. Cell 2011, 144:986-998.
23. Stark C., Breitkreutz B.J., Reguly T., Boucher L., Breitkreutz A., Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res 2006, 34:D535-539.
24. Consortium T.U. UniProt: a hub for protein information. Nucleic Acids Res. 2015, 43:D204-212.
25. Cumming R.C., Lightfoot J., Beard K., Youssoufian H., O'Brien P.J., Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat. Med. 2001, 7:814-820.
26. Reuter T.Y., Medhurst A.L., Waisfisz Q., Zhi Y., Herterich S., Hoehn H., Gross H.J., Joenje H., Hoatlin M.E., Mathew C.G., Huber P.A. Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport. Exp. Cell Res. 2003, 289:211-221.
27. Piredda L., Farrace M.G., Lo Bello M., Malorni W., Melino G., Petruzzelli R., Piacentini M. Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J. 1999, 13:355-364.
28. Koh J., Ali-Osman F. GSTP1 forms a stable, non-covalent complex with the tissue transglutaminase TGM2 in human glioblastoma cells. Proc. Annu. Meet. Am. Assoc. Cancer Res. 2007, 98:4488.
29. Henderson C.J., Ritchie K.J., McLaren A., Chakravarty P., Wolf C.R. Increased skin papilloma formation in mice lacking glutathione transferase GSTP. Cancer Res. 2011, 71:7048-7060.
30. Nensa F.M., Neumann M.H., Schrotter A., Przyborski A., Mastalski T., Susdalzew S., Loobetae C., Helling S., El Magraoui F., Erdmann R., Meyer H.E., Uszkoreit J., Eisenacher M., Suh J., Guenette S.Y., Rohner N., Kogel D., Theiss C., Marcus K., Muller T. Amyloid beta a4 precursor protein-binding family B member 1 (FE65) interactomics revealed synaptic vesicle glycoprotein 2A (SV2A) and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) as new binding proteins in the human brain. Mol. Cell. Proteomics 2014, 13:475-488.
31. Szklarczyk D., Franceschini A., Wyder S., Forslund K., Heller D., Huerta-Cepas J., Simonovic M., Roth A., Santos A., Tsafou K.P., Kuhn M., Bork P., Jensen L.J., von Mering C. STRING v10: protein-protein interaction networks integrated over the tree of life. Nucleic Acids Res. 2015, 43:D447-452.
32. Rossjohn J., McKinstry W.J., Oakley A.J., Verger D., Flanagan J., Chelvanayagam G., Tan K.L., Board P.G., Parker M.W. Human theta class glutathione transferase: the crystal structure reveals a sulfate-binding pocket within a buried active site. Structure 1998, 6:309-322.
33. Wang L., Xu J., Ji C., Gu S., Lv Y., Li S., Xu Y., Xie Y., Mao Y. Cloning, expression and characterization of human glutathione S-transferase Omega 2. Int. J. Mol. Med. 2005, 16:19-27.
34. Galli F. Interactions of polyphenolic compounds with drug disposition and metabolism. Curr. Drug Metab. 2007, 8:830-838.
35. Umamaheswaran G., Kumar D.K., Adithan C. Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters-a review with Indian perspective. Indian J. Med. Res. 2014, 139:27-65.
36. Eshkoor S., Ismail P., Rahman S., Moin S., Adon M. Role of the CYP1A2 gene polymorphism on early ageing from occupational exposure. Balkan J. Med. Genet. 2013, 16:45-52.
37. Neafsey P., Ginsberg G., Hattis D., Johns D.O., Guyton K.Z., Sonawane B. Genetic polymorphism in CYP2E1: population distribution of CYP2E1 activity. J. Toxicol. Environ. Health B Crit. Rev. 2009, 12:362-388.
38. Wang X., Simpson E.R., Brown K.A. p53: protection against tumor growth beyond effects on cell cycle and apoptosis. Cancer Res. 2015, 75:5001-5007.
39. Luchetti F., Betti M., Canonico B., Arcangeletti M., Ferri P., Galli F., Papa S. ERK MAPK activation mediates the antiapoptotic signaling of melatonin in UVB-stressed U937 cells. Free Radic. Biol. Med. 2009, 46:339-351.
40. Leppa S., Bohmann D. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 1999, 18:6158-6162.
41. Townsend D.M., Manevich Y., He L., Hutchens S., Pazoles C.J., Tew K.D. Novel role for glutathione S-transferase pi. regulator of protein S-Glutathionylation following oxidative and nitrosative stress. J. Biol. Chem. 2009, 284:436-445.
42. Ralat L.A., Misquitta S.A., Manevich Y., Fisher A.B., Colman R.F. Characterization of the complex of glutathione S-transferase pi and 1-cysteine peroxiredoxin. Arch. Biochem. Biophys. 2008, 474:109-118.
43. Cho S.G., Lee Y.H., Park H.S., Ryoo K., Kang K.W., Park J., Eom S.J., Kim M.J., Chang T.S., Choi S.Y., Shim J., Kim Y., Dong M.S., Lee M.J., Kim S.G., Ichijo H., Choi E.J. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J. Biol. Chem. 2001, 276:12749-12755.
44. Dorion S., Lambert H., Landry J. Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. J. Biol. Chem. 2002, 277:30792-30797.
45. Adler V., Yin Z., Fuchs S.Y., Benezra M., Rosario L., Tew K.D., Pincus M.R., Sardana M., Henderson C.J., Wolf C.R., Davis R.J., Ronai Z. Regulation of JNK signaling by GSTp. EMBO J. 1999, 18:1321-1334.
46. Manevich Y., Feinstein S.I., Fisher A.B. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3780-3785.
47. Sanchez-Gomez F.J., Dorado C.G., Ayuso P., Agundez J.A., Pajares M.A., Perez-Sala D. Modulation of GSTP 1-1 oligomerization by electrophilic inflammatory mediators and reactive drugs. Inflamm. Allergy Drug Targets 2013, 12:162-171.
48. Pettigrew N.E., Colman R.F. Heterodimers of glutathione S-transferase can form between isoenzyme classes pi and mu. Arch. Biochem. Biophys. 2001, 396:225-230.
49. Cromer B.A., Morton C.J., Board P.G., Parker M.W. From glutathione transferase to pore in a CLIC. Eur. Biophys. J. 2002, 31:356-364.
50. Sheehan D., Meade G., Foley V.M., Dowd C.A. Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem. J. 2001, 360:1-16.
51. Ruscoe J.E., Rosario L.A., Wang T., Gate L., Arifoglu P., Wolf C.R., Henderson C.J., Ronai Z., Tew K.D. Pharmacologic or genetic manipulation of glutathione S-transferase P 1-1 (GSTpi) influences cell proliferation pathways. J. Pharmacol. Exp. Ther. 2001, 298:339-345.
52. Wu Y., Fan Y., Xue B., Luo L., Shen J., Zhang S., Jiang Y., Yin Z. Human glutathione S-transferase P 1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 2006, 25:5787-5800.
53. Asakura T., Sasagawa A., Takeuchi H., Shibata S., Marushima H., Mamori S., Ohkawa K. Conformational change in the active center region of GST P 1-1 due to binding of a synthetic conjugate of DXR with GSH, enhanced JNK-mediated apoptosis. Apoptosis 2007, 12:1269-1280.
54. Holley S.L., Fryer A.A., Haycock J.W., Grubb S.E., Strange R.C., Hoban P.R. Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis. Carcinogenesis 2007, 28:2268-2273.
55. Aoki H., Kang P.M., Hampe J., Yoshimura K., Noma T., Matsuzaki M., Izumo S. Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J. Biol. Chem. 2002, 277:10244-10250.
56. Klatt P., Molina E.P., Lamas S. Nitric oxide inhibits c-Jun DNA binding by specifically targeted S-glutathionylation. J. Biol. Chem. 1999, 274:15857-15864.
57. Thevenin A.F., Zony C.L., Bahnson B.J., Colman R.F. GST pi modulates JNK activity through a direct interaction with JNK substrate, ATF2. Protein Sci. 2011, 20:834-848.
58. Morceau F., Duvoix A., Delhalle S., Schnekenburger M., Dicato M., Diederich M. Regulation of glutathione S-transferase P 1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells. Biochem. Pharmacol. 2004, 67:1227-1238.
59. Duvoix A., Morceau F., Delhalle S., Schmitz M., Schnekenburger M., Galteau M.M., Dicato M., Diederich M. Induction of apoptosis by curcumin: mediation by glutathione S-transferase P 1-1 inhibition. Biochem. Pharmacol. 2003, 66:1475-1483.
60. Duvoix A., Delhalle S., Blasius R., Schnekenburger M., Morceau F., Fougere M., Henry E., Galteau M.M., Dicato M., Diederich M. Effect of chemopreventive agents on glutathione S-transferase P 1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. Biochem. Pharmacol. 2004, 68:1101-1111.
61. Zhao X., Fan Y., Shen J., Wu Y., Yin Z. Human glutathione S-transferase P1 suppresses MEKK1-mediated apoptosis by regulating MEKK1 kinase activity in HEK293 cells. Mol. Cells 2006, 21:395-400.
62. Sun K.H., Chang K.H., Clawson S., Ghosh S., Mirzaei H., Regnier F., Shah K. Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity. J. Neurochem. 2011, 118:902-914.
63. Manevich Y., Sweitzer T., Pak J.H., Feinstein S.I., Muzykantov V., Fisher A.B. 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11599-11604.
64. R.S. Wilson, A. Khanal, B. Bahnson, Peroxiredoxin VI in complex with a transition inhibitor FASEB J. (2009) 504.508.
65. Kim Y.J., Lee W.S., Ip C., Chae H.Z., Park E.M., Park Y.M. Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex. Cancer Res. 2006, 66:7136-7142.
66. Manevich Y., Fisher A.B. Peroxiredoxin 6 a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic. Biol. Med. 2005, 38:1422-1432.
67. Ralat L.A., Manevich Y., Fisher A.B., Colman R.F. Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase pi with activity changes in both enzymes. Biochemistry 2006, 45:360-372.
68. Ralat L.A., Colman R.F. Identification of tyrosine 79 in the tocopherol binding site of glutathione S-transferase pi. Biochemistry 2006, 45:12491-12499.
69. 2+-independent phospholipase A2 in synthesis of lung dipalmitoyl phosphatidylcholine. Am. J. Physiol. 1997, 272:L238-243.
70. Bouhafs R.K., Jarstrand C. Interaction between lung surfactant and nitric oxide production by alveolar macrophages stimulated by group B streptococci. Pediatr. Pulmonol. 2000, 30:106-113.
71. Bhandari V., Johnson L., Smith-Kirwin S., Vigliotta G., Funanage V., Chander A. Hyperoxia and nitric oxide reduce surfactant components (DSPC and surfactant proteins) and increase apoptosis in adult and fetal rat type II pneumocytes. Lung 2002, 180:301-317.
72. Miles P.R., Bowman L., Rengasamy A., Huffman L. Alveolar type II cell cNOS activity and ATP levels are increased by lung surfactant or DPPC vesicles. Am. J. Physiol. 1997, 273:L339-346.
73. 2+ entry and vascular tone in intact aorta. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H2466-2474.
74. Wu Y.Z., Manevich Y., Baldwin J.L., Dodia C., Yu K., Feinstein S.I., Fisher A.B. Interaction of surfactant protein A with peroxiredoxin 6 regulates phospholipase A2 activity. J. Biol. Chem. 2006, 281:7515-7525.
75. Yamasaki M., Miyamoto Y., Chujo H., Nishiyama K., Tachibana H., Yamada K. Trans10, cis12-conjugated linoleic acid induces mitochondria-related apoptosis and lysosomal destabilization in rat hepatoma cells. Biochim. Biophys. Acta 2005, 1735:176-184.
76. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., Kirk M., Freeman B.A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 1994, 269:26066-26075.
77. Davis I.C., Zhu S., Sampson J.B., Crow J.P., Matalon S. Inhibition of human surfactant protein A function by oxidation intermediates of nitrite. Free Radic. Biol. Med. 2002, 33:1703-1713.
78. Haagsman H.P., van Golde L.M. Synthesis and assembly of lung surfactant. Annu. Rev. Physiol. 1991, 53:441-464.
79. Guidot D.M., Brown L.A. Mitochondrial glutathione replacement restores surfactant synthesis and secretion in alveolar epithelial cells of ethanol-fed rats. Alcohol Clin. Exp. Res. 2000, 24:1070-1076.
80. 2+ entry. J. Biol. Chem. 2003, 278:11909-11915.
81. Packard C.J., O'Reilly D.S., Caslake M.J., McMahon A.D., Ford I., Cooney J., Macphee C.H., Suckling K.E., Krishna M., Wilkinson F.E., Rumley A., Lowe G.D. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 2000, 343:1148-1155.
82. Lian X., Yan C., Yang L., Xu Y., Du H. Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 286:L801-807.
83. Blomquist C.H., Kotts C.E., Hakanson E.Y. Phospholipase A2 inactivation of microsomal 17 beta-hydroxysteroid oxidoreductase: rates of phospholipid hydrolysis and enzyme inactivation, effects of hydrolysis products and properties of the phospholipase A2-treated enzyme. Steroids 1980, 36:97-113.
84. Padgett D.A., Loria R.M., Sheridan J.F. Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol. J. Neuroimmunol. 1997, 78:203-211.
85. Ritchie K.J., Henderson C.J., Wang X.J., Vassieva O., Carrie D., Farmer P.B., Gaskell M., Park K., Wolf C.R. Glutathione transferase pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane. Cancer Res. 2007, 67:9248-9257.
86. Gate L., Majumdar R.S., Lunk A., Tew K.D. Increased myeloproliferation in glutathione S-transferase pi-deficient mice is associated with a deregulation of JNK and Janus kinase/STAT pathways. J. Biol. Chem. 2004, 279:8608-8616.
87. Vidanes G.M., Paton V., Wallen E., Peehl D.M., Navone N., Brooks J.D. Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells. Prostate 2002, 51:225-230.
88. Shu W., Lu M.M., Zhang Y., Tucker P.W., Zhou D., Morrisey E.E. Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development 2007, 134:1991-2000.
89. Banham A.H., Boddy J., Launchbury R., Han C., Turley H., Malone P.R., Harris A.L., Fox S.B. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. Prostate 2007, 67:1091-1098.
90. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 2009, 9:798-809.
91. Kou X., Chen N., Feng Z., Luo L., Yin Z. GSTP1 negatively regulates Stat3 activation in epidermal growth factor signaling. Oncol. Lett. 2013, 5:1053-1057.
92. Chen D., Liu J., Rui B., Gao M., Zhao N., Sun S., Bi A., Yang T., Guo Y., Yin Z., Luo L. GSTpi protects against angiotensin II-induced proliferation and migration of vascular smooth muscle cells by preventing signal transducer and activator of transcription 3 activation. Biochim. Biophys. Acta 2014, 1843:454-463.
93. Tebay L.E., Robertson H., Durant S.T., Vitale S.R., Penning T.M., Dinkova-Kostova A.T., Hayes J.D. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Rad. Biol. Med. 2015, 88:108-146.
94. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
95. Zhang D.D., Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 2003, 23:8137-8151.
96. Jain A.K., Jaiswal A.K. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J. Biol. Chem. 2006, 281:12132-12142.
97. Huang H.C., Nguyen T., Pickett C.B. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 2002, 277:42769-42774.
98. Cullinan S.B., Diehl J.A. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J. Biol. Chem. 2004, 279:20108-20117.
99. Cullinan S.B., Zhang D., Hannink M., Arvisais E., Kaufman R.J., Diehl J.A. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell. Biol. 2003, 23:7198-7209.
100. Kang K.W., Choi S.H., Kim S.G. Peroxynitrite activates NF-E2-related factor 2/antioxidant response element through the pathway of phosphatidylinositol 3-kinase: the role of nitric oxide synthase in rat glutathione S-transferase A2 induction. Nitric Oxide 2002, 7:244-253.
101. Yu R., Chen C., Mo Y.Y., Hebbar V., Owuor E.D., Tan T.H., Kong A.N. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J. Biol. Chem. 2000, 275:39907-39913.
102. Canning P., Sorrell F.J., Bullock A.N. Structural basis of Keap1 interactions with Nrf2. Free Radic. Biol. Med. 2015, 88:101-107.
103. Reddy N.M., Kleeberger S.R., Bream J.H., Fallon P.G., Kensler T.W., Yamamoto M., Reddy S.P. Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling. Oncogene 2008, 27:5821-5832.
104. Bartolini D., Piroddi M., Tidei C., Giovagnoli S., Pietrella D., Manevich Y., Tew K.D., Giustarini D., Rossi R., Townsend D.M., Santi C., Galli F. Reaction kinetics and targeting to cellular glutathione S-transferase of the glutathione peroxidase mimetic PhSeZnCl and its D. microparticle formulation. Free Radic. Biol. Med. 2015, 78:56-65.
105. Kolonin M.G., Zhong J., Finley R.L. Interaction mating methods in two-hybrid systems. Methods Enzymol. 2000, 328:26-46.
106. Einhauer A., Jungbauer A. The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins. J. Biochem. Biophys. Methods 2001, 49:455-465.
107. Puig O., Caspary F., Rigaut G., Rutz B., Bouveret E., Bragado-Nilsson E., Wilm M., Seraphin B. The tandem affinity purification (TAP) method: a general procedure of protein complex purification. Methods 2001, 24:218-229.